The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE
Open accessAbstract
Autoantibodies against double-stranded DNA (dsDNA) and nucleosomes represent a hallmark of systemic lupus erythematosus (SLE). However, the mechanisms involved in breaking the immunological tolerance against these poorly immunogenic nuclear components are not fully understood. Impaired phagocytosis of apoptotic cells with consecutive release of nuclear antigens may contribute to the immune pathogenesis. The architectural chromosomal protein and proinflammatory mediator high mobility group box protein 1 (HMGB1) is tightly attached to the chromatin of apoptotic cells. We demonstrate that HMGB1 remains bound to nucleosomes released from late apoptotic cells in vitro. HMGB1–nucleosome complexes were also detected in plasma from SLE patients. HMGB1-containing nucleosomes from apoptotic cells induced secretion of interleukin (IL) 1β, IL-6, IL-10, and tumor necrosis factor (TNF) α and expression of costimulatory molecules in macrophages and dendritic cells (DC), respectively. Neither HMGB1-free nucleosomes from viable cells nor nucleosomes from apoptotic cells lacking HMGB1 induced cytokine production or DC activation. HMGB1-containing nucleosomes from apoptotic cells induced anti-dsDNA and antihistone IgG responses in a Toll-like receptor (TLR) 2–dependent manner, whereas nucleosomes from living cells did not. In conclusion, HMGB1–nucleosome complexes activate antigen presenting cells and, thereby, may crucially contribute to the pathogenesis of SLE via breaking the immunological tolerance against nucleosomes/dsDNA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Self-citationRelease of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
Self-citationHMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Immunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787
Self-citationCasciola-Rosen, L. A., Anhalt, G., & Rosen, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1317 · Cited by 1,717
Park, J. S., Svetkauskaite, D., He, Q., Kim, J.-Y., Strassheim, D., Ishizaka, A., & Abraham, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306793200 · Cited by 1,562
Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus
Blanco, P., Palucka, A. K., Gill, M., Pascual, V., & Banchereau, J. (2001) · Science · doi:10.1126/science.1064890 · Cited by 1,266
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434651100 · Cited by 1,126
Christensen, S. R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R. A., & Shlomchik, M. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.013 · Cited by 1,090
Pathogenesis of systemic lupus erythematosus
Mok, C. C., & Lau, C. S. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.7.481 · Cited by 942
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523025 · Cited by 849
Tan, E. M., Schur, P. H., Carr, R. I., & Kunkel, H. G. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105479 · Cited by 845
Bustin, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5237 · Cited by 845
Herrmann, M., Voll, R. E., Zoller, O. M., Hagenhofer, M., Ponner, B. B., & Kalden, J. R. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7<1241::aid-art15>3.0.co;2-h · Cited by 839
Self-citationEndogenous ligands of Toll-like receptors
Tsan, M.-F., & Gao, B. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0304127 · Cited by 685
Hahn, B. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805073381906 · Cited by 682
HMG1 and 2, and related ‘architectural’ DNA-binding proteins
Thomas, J. O., & Travers, A. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01801-1 · Cited by 618
HMGB1 is an endogenous immune adjuvant released by necrotic cells
Rovere‐Querini, P., Capobianco, A., Scaffidi, P., Valentinis, B., Catalanotti, F., Giazzon, M., Dumitriu, I. E., Müller, S., Iannacone, M., Traversari, C., et al. (2004) · EMBO reports · doi:10.1038/sj.embor.7400205 · Cited by 591
Self-citationSystemic Exposure to Irradiated Apoptotic Cells Induces Autoantibody Production
Mevorach, D., Zhou, J. L., Song, X., & Elkon, K. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.387 · Cited by 567
The extracellular release of HMGB1 during apoptotic cell death
Bell, C. W., Jiang, W., Reich, C. F., & Pisetsky, D. S. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00616.2005 · Cited by 538
Calogero, S., Grassi, F., Aguzzi, A., Voigtländer, T., Ferrier, P., Ferrari, S., & Bianchi, M. E. (1999) · Nature Genetics · doi:10.1038/10338 · Cited by 528
Self-citationLiliensiek, B., Weigand, M. A., Bierhaus, A., Nicklas, W., Kasper, M., Hofer, S., Plachky, J., Gröne, H.-J., Kurschus, F. C., Schmidt, A. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18704 · Cited by 524
HMG proteins: dynamic players in gene regulation and differentiation
Bianchi, M. E., & Agresti, A. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.08.007 · Cited by 521
Self-citationBoulé, M. W., Broughton, C., Mackay, F., Akira, S., Marshak-Rothstein, A., & Rifkin, I. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031942 · Cited by 518
Cross-regulation of TNF and IFN-α in autoimmune diseases
Palucka, A. K., Blanck, J.-P., Bennett, L., Pascual, V., & Banchereau, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408506102 · Cited by 516
RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages
Kokkola, R., Andersson, Å., Mullins, G., Östberg, T., Treutiger, C. ‐., Arnold, B., Nawroth, P., Andersson, U., Harris, R. A., & Harris, H. E. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2005.01534.x · Cited by 496
Taniguchi, N., Kawahara, K., Yone, K., Hashiguchi, T., Yamakuchi, M., Goto, M., Inoue, K., Yamada, S., Ijiri, K., Matsunaga, S., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10859 · Cited by 482
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA
Ivanov, S., Dragoi, A.-M., Wang, X., Dallacosta, C., Louten, J., Musco, G., Sitia, G., Yap, G. S., Wan, Y., Biron, C. A., et al. (2007) · Blood · doi:10.1182/blood-2006-09-044776 · Cited by 470
Self-citationToll-like receptors; their physiological role and signal transduction system
Takeuchi, O., & Akira, S. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00010-8 · Cited by 466
Messmer, D., Yang, H., Telusma, G., Knoll, F., Li, J., Messmer, B., Tracey, K. J., & Chiorazzi, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.307 · Cited by 447
Winfield, J. B., Faiferman, I., & Koffler, D. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108626 · Cited by 405
Recognizing death: the phagocytosis of apoptotic cells
Platt, N., da Silva, R. P., & Gordon, S. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01329-4 · Cited by 375
High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis
Kokkola, R., Sundberg, E., Ulfgren, A. ‐., Palmblad, K., Li, J., Wang, H., Ulloa, L., Yang, H., Yan, X. ‐., Furie, R., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10540 · Cited by 290
Cytokine production, serum levels and disease activity in systemic lupus erythematosus.
Gröndal, G., Gunnarsson, I., Rönnelid, J., Rogberg, S., Klareskog, L., & Lundberg, I. E. (2000) · PubMed · Cited by 287
Merenmies, J., Pihlaskari, R., Laitinen, J., Wartiovaara, J., & Rauvala, H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55361-8 · Cited by 242
Michl, J., Pieczonka, M. M., Unkeless, J. C., & Silverstein, S. C. (1979) · The Journal of experimental medicine · doi:10.1084/jem.150.3.607 · Cited by 233
Responsiveness of autoimmune and normal mice to nucleic acid antigens.
Madaio, M. P., Hodder, S., Schwartz, R. S., & Stollar, B. D. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.2.872 · Cited by 223
Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice
Ehrenstein, M. R., Katz, D. R., Griffiths, M. H., Papadaki, L., Winkler, T. H., Kalden, J. R., & Isenberg, D. A. (1995) · Kidney International · doi:10.1038/ki.1995.341 · Cited by 220
Self-citationManfredi, A. A., Rovere, P., Galati, G., Heltai, S., Bozzolo, E., Soldini, L., Davoust, J., Balestrieri, G., Tincani, A., & Sabbadini, M. G. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199802)41:2<205::aid-art4>3.0.co;2-0 · Cited by 205
Self-citationThe role of tumor necrosis factor-alpha in systemic lupus erythematosus
Aringer, M., & Smolen, J. S. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2341 · Cited by 177
The key role of nucleosomes in lupus
Amoura, Z., Pietté, J. C., Bach, J. F., & Koutouzov, S. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199905)42:5<833::aid-anr1>3.0.co;2-t · Cited by 165
Factors masking HMGB1 in human serum and plasma
Urbonaviciute, V., Fürnrohr, B. G., Weber, C., Haslbeck, M., Wilhelm, S., i, M. H., & Voll, R. E. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306196 · Cited by 157
Self-citationPopovic, K., Ek, M., Espinosa, A., Padyukov, L., Harris, H. E., Wahren‐Herlenius, M., & Nyberg, F. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21398 · Cited by 140
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice
Sitia, G., Iannacone, M., Müller, S., Bianchi, M. E., & Guidotti, L. G. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306173 · Cited by 139
Self-citationDecker, P., Singh‐Jasuja, H., Haager, S., Kötter, I., & Rammensee, H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3326 · Cited by 116
van Nieuwenhuijze, A. E. M., van Lopik, T., Smeenk, R. J. T., & Aarden, L. A. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.1.10 · Cited by 113
DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis
Oliveri, M., Daga, A., Cantoni, C., Lunardi, C., Millo, R., & Puccetti, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200103)31:3<743::aid-immu743>3.0.co;2-9 · Cited by 111
Granucci, F., Foti, M., & Ricciardi‐Castagnoli, P. (2005) · Advances in immunology · doi:10.1016/s0065-2776(05)88006-x · Cited by 97
Böttcher, A., Gaipl, U. S., Fürnrohr, B. G., i, M. H., Girkontaitė, I., Kalden, J. R., & Voll, R. E. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21660 · Cited by 93
Self-citationCastiblanco, J., Varela, D. C., Castaño‐Rodríguez, N., Rojas‐Villarraga, A., Zapata, M. E. H., & Anaya, J. (2008) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2008.03.001 · Cited by 91
Barkauskaite, V., Ek, M., Popović, K. J., Harris, H. E., Wahren‐Herlenius, M., & Nyberg, F. (2007) · Lupus · doi:10.1177/0961203307081895 · Cited by 91
Al‐Janadi, M., Al-Dalaan, A., Al-Balla, S. R., Al-Humaidi, M. A., & Raziuddin, S. (1996) · Journal of Clinical Immunology · doi:10.1007/bf01541225 · Cited by 66
Williams, R. C., Malone, C. C., Meyers, C., Decker, P., & Muller, S. (2001) · PubMed · Cited by 65
Binding Properties of Human Anti‐DNA Antibodies to Cloned Human DNA Fragments
Sano, H., TAKAI, O., Harata, N. C., YOSHINAGA, K., KODAMA‐KAMADA, I., & Sasaki, T. (1989) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1989.tb01188.x · Cited by 64
Jiang, W., & Pisetsky, D. S. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074484 · Cited by 63
Spiller, S., Dreher, S., Meng, G., Grabiec, A., Thomas, W., Härtung, T., Pfeffer, K., Hochrein, H., Brade, H., Bessler, W. G., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610340200 · Cited by 49
Self-citationWhat triggers anti-dsDNA antibodies?
i, M. H., Zoller, O., Hagenhofer, M., Voll, R. E., & Kalden, J. R. (1996) · Molecular Biology Reports · doi:10.1007/bf00351179 · Cited by 45
Self-citationEndonuclease Activation and Chromosomal DNA Fragmentation during Apoptosis in Leukemia Cells
Yoshida, A., Pommier, Y. G., & Ueda, T. (2006) · International Journal of Hematology · doi:10.1007/bf03342699 · Cited by 45
Autoantibodies in SLE but not in scleroderma react with protein-stripped nucleosomes
Suer, W., Dähnrich, C., Schlumberger, W., & STÖCKER, W. (2004) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.02.002 · Cited by 43
The expression of plasma nucleosomes in mice undergoing in vivo apoptosis
Jiang, N., Reich, C. F., Monestier, M., & Pisetsky, D. S. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(02)00027-x · Cited by 39
Decker, P. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.11.009 · Cited by 34
Requirements for Proteolysis during Apoptosis
Vaux, D. L., Wilhelm, S., & Häcker, G. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6502 · Cited by 22
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
Gergely, P., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., Banki, K., Phillips, P. E., & Perl, A. (2002) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200201)46:1 · Cited by 5
Cited by
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
HMGB1 is a therapeutic target for sterile inflammation and infection
Andersson, U., & Tracey, K. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101323 · Cited by 1,437
HMGB1 and RAGE in Inflammation and Cancer
Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R., & Coyle, A. J. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132603 · Cited by 1,436
PAMP s and DAMP s: signal 0s that spur autophagy and immunity
Tang, D., Kang, R., Coyne, C. B., Zeh, H. J., & Lotze, M. T. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01146.x · Cited by 1,221
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Mackensen, A., Müller, F., Mougiakakos, D., Böltz, S., Wilhelm, A., Aigner, M., Völkl, S., Simon, D., Kleyer, A., Munoz, L., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02017-5 · Cited by 1,092
Self-citation
Metadata
- Authors
- Urbonaviciute, V., Fürnrohr, B. G., Meister, S., Munoz, L., Heyder, P., De Marchis, F., Bianchi, M. E., Kirschning, C., Wagner, H., Manfredi, A. A., Kalden, J. R., Schett, G., Rovere-Querini, P., Herrmann, M., & Voll, R. E.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2008-12-08
- Volume
- 205
- Issue
- 13
- Pages
- 3007-3018
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2161367998
- Cited by
- 517
- References
- 68
- FWCI
- 27.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.